TGFB1 and neoplasm: Prior studies have shown [13–16] that TGFβ, secreted by tumor cells in an autocrine loop, or in a paracrine fashion by immunosuppressive cells or stroma in the tumor microenvironment, can inhibit the anti-tumor activity of effector cells such as NK or T cells.